High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis (Ledderhose's disease)

被引：25

作者：

Karsten Knobloch

Peter M Vogt

机构：

[1] Plastic Hand and Reconstructive Surgery, Burn Center, Hannover Medical School, Hannover 30625

[2] Plastic Hand- and Reconstructive Surgery, Hannover Medical School, Hannover

来源：

BMC Research Notes | / 5卷 / 1期

关键词：

Extracorporeal shockwave therapy (ESWT); Fibromatosis; Ledderhose; Pain;

D O I：

10.1186/1756-0500-5-542

中图分类号：

学科分类号：

摘要：

Background: Plantar fibromatosis is a benign disease creating nodules on the medial plantar side of affected patients. While surgical removal is regarded as the therapeutic mainstay, recurrence rates and impairment of daily activities remains substantial. High-energy focussed extracorporeal shockwave therapy has been suggested to be potentially effective in plantar fibromatosis in terms of pain reduction. Hypothesis. High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis. Findings. A total number of six patients (5 males, 58±4 years) were included with plantar fibromatosis (Ledderhose's disease) associated with pain. Three patients were operated on previously, one had concomitant Dupuytren's contracture. High-energy focussed ESWT was applied using a Storz Duolith SD1 (2000 impulses, 3 Hz, 1.24 mJ/mm2) in two sessions with 7 days between. Pain was 6±2 at baseline, 2±1 after 14 days and 1±1 after 3 months. Softening of the nodules was noted by all patients. No adverse effects were noted. Conclusions: High-energy focussed extracorporeal shockwave energy reduces pain in painful plantar fibromatosis (Morbus Ledderhose). Further large-scale prospective trials are warranted to elucidate the value of high-energy focussed extracorporeal shockwave therapy (ESWT) in plantar fibromatosis in terms of recurrence and efficacy. © 2012 Knobloch and Vogt; licensee BioMed Central Ltd.

引用

共 7 条

[1]

Zgonis T., Peter Jolly G., Polyzois V., Kanuck D.M., Stamatis E.D., Plantar fibromatosis, Clinics in Podiatric Medicine and Surgery, 22, 1, pp. 11-18, (2005)

[2]

Van Der Veer W.M., Hamburg S.M., De Gast A., Niessen F.B., Recurrence of plantar fibromatosis after plantar fasciectomy: Single-center long-term results, Plast Reconstr Surg, 122, 2, pp. 486-491, (2008)

[3]

De Bree E., Zoetmulder F.A.N., Keus R.B., Peterse H.L., Van Coevorden F., Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy, American Journal of Surgery, 187, 1, pp. 33-38, (2004)

[4]

Seegenschmiedt M.H., Attassi M., Strahlentherapie beim Morbus Ledderhose - Indikation und Klinische Ergebnisse, Strahlentherapie und Onkologie, 179, 12, pp. 847-853, (2003)

[5]

Palmieri A., Imbimbo C., Longo N., Fusco P., Verze F., Mangiopia F., A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporal shock wave therapy for the treatment of Peyronie's disease, Eur Urol, 56, 2, pp. 363-369, (2009)

[6]

Srirangam S.J., Manikandan R., Hussain J., Collins G.N., O'Reilly P.H., Long-term results of extracorporeal shockwave therapy for Peyronie's disease, Journal of Endourology, 20, 11, pp. 880-884, (2006)

[7]

Knobloch K., Kuehn M., Vogt P.M., Focussed extracorporeal shockwave therapy in Dupuytren's disease-a hypothesis, Med Hypotheses, 76, 5, pp. 635-637, (2011)

← 1 →